Brief: Concord Biotech posts Sept-Quarter Consol Net Profit 635.8 Million Rupees
13/11/2025 13:47
Nov 13 (Reuters) - Concord Biotech Ltd CONB.NS: CONCORD BIOTECH LTD SEPT-QUARTER CONSOL NET PROFIT 635.8 MILLION RUPEES CONCORD BIOTECH SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.47 BILLION RUPEES Source text: [ID:] Further company coverage: CONB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval